openPR Logo
Press release

Mitotic Inhibitors Market Top Industry Players, Revenue By 2025

02-23-2018 10:06 AM CET | Health & Medicine

Press release from: Transparency Market Research

Mitotic Inhibitors Market Top Industry Players, Revenue By 2025

Mitosis is a process of cell division, wherein a cell divides into an identical cell through multiplication and separation of its chromosomes. The separation of chromosomes is carried out by microtubules in the cell. Mitotic inhibitors are substances that inhibit the separation of chromosomes by binding to tubulin, which are the building blocks of microtubules. Mitotic inhibitors are naturally derived products from various plant extracts. Mitotic inhibitors are widely used in the life sciences and medical industries. Mitotic inhibitor drugs are used to treat various types of cancer using chemotherapy. These drugs are targeted at cancer cells to stop multiplication and help eradicate cancer.

Mitotic inhibitors are widely used in life sciences for various studies such as study of chromosomes (cytogenetic). Several industry players are investing in the development and commercialization of mitotic inhibitor drugs to treat cancer and other medical conditions. Natural occurrence and efficiency in treating cancer are likely to increase the uptake of these drugs during the forecast period. Besides treating cancer, mitotic inhibitors have applications in antibiotics to control fungal infection and some are found to be useful in treating gout. Investments are being made to expand applications of mitotic inhibitors in the health care industry. However, several side effects are associated with the use of mitotic inhibitor drugs in cancer treatment, including nerve damage, muscle and joint pain, and nausea & vomiting. This in turn is anticipated to limit their use, thereby hampering market growth.



Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34148



The Global Mitotic Inhibitors Market can be segmented based on product type, application, end-user, and region. In terms of product type, the market can be divided into taxanes, vinca alkaloids, colchicine, podophyllotoxins, and others. The taxanes and vinca alkaloids segments are anticipated to account for significant shares of the global mitotic inhibitors market and are likely to experience strong growth during the forecast period from 2017 to 2025. Availability of large number of cancer drugs is expected to augment these segments. Based on application, the global mitotic inhibitors market can be segmented into therapeutics and life sciences. High consumption and high cost of therapeutic mitotic inhibitors are anticipated to drive the therapeutics segment during the forecast period. Based on end-user, the market can be classified into hospitals, ambulatory surgical centers, academic research institutes, and others.



Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=34148



Geographically, the global mitotic inhibitors market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to constitute a large share of the global market during the forecast period, owing to high consumption of these drugs for cancer treatment. Moreover, high usage of mitotic inhibitors in life sciences in this region is projected to fuel the growth of the mitotic inhibitors market in North America during the forecast period from 2017 to 2025. Europe is anticipated to account for a significant share of the global market during the forecast period.

According to the World Health Organization, around 3.7 million new cancer cases are registered in Europe each year. Increase in health care expenditure in Asia Pacific is likely to propel the market during the forecast period. Furthermore, increasing investment in life sciences is projected to boost the growth of the mitotic inhibitors market in Asia Pacific.

Major players operating in the global mitotic inhibitors market are Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Eisai Co., Ltd., Bristol-Myers Squibb Company, Celgene Corporation, Novartis AG, Pharm US LLC, Merck KGaA, AdooQ BioScience, and Enzo Life Sciences, Inc., among others.



View Report -

https://www.transparencymarketresearch.com/mitotic-inhibitors-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mitotic Inhibitors Market Top Industry Players, Revenue By 2025 here

News-ID: 955038 • Views:

More Releases from Transparency Market Research

Antioxidants Market to Reach US$ 8.7 Billion by 2036, Fueled by Health Awareness and Clean-Label Demand
Antioxidants Market to Reach US$ 8.7 Billion by 2036, Fueled by Health Awareness …
The global antioxidants market was valued at US$ 5.1 Billion in 2025 and is projected to reach US$ 8.7 Billion by 2036, expanding at a CAGR of 5.0% from 2026 to 2036. The market is witnessing steady growth driven by increasing health awareness, expanding food preservation applications, rising demand for functional foods, and growing use of antioxidants in cosmetics and pharmaceuticals. Antioxidants are compounds that inhibit oxidation and neutralize free radicals,
Medical Device Coatings Market to Surpass USD 81.8 Bn by 2031 at 19.4% CAGR | TMR
Medical Device Coatings Market to Surpass USD 81.8 Bn by 2031 at 19.4% CAGR | TM …
The global medical device coatings market was valued at over US$ 11.8 Bn in 2020 and is projected to expand at a robust CAGR of 19.4% from 2021 to 2031, surpassing US$ 81.8 Bn by the end of 2031. Rising demand for infection control, enhanced biocompatibility, and advanced surgical devices is significantly driving market expansion worldwide. Market Overview: The industry is witnessing rapid technological advancements in hydrophilic, antimicrobial, anti-thrombogenic, and drug-eluting
Mining Explosives Market to Reach US$ 41.3 Billion by 2036 Driven by Rising Mineral Extraction Demand
Mining Explosives Market to Reach US$ 41.3 Billion by 2036 Driven by Rising Mine …
The Mining Explosives Market plays a crucial role in global mineral extraction and infrastructure development. Explosives are widely used in surface and underground mining operations to fragment rock, enabling the extraction of coal, metals, and industrial minerals. As global demand for energy, construction materials, and critical minerals continues to rise, the mining explosives industry is experiencing steady growth supported by technological advancements and expanding mining activities. Download Your Complimentary Report -
Specialty Surfactants Market Outlook 2036: Bio-Based Dominance, 1.9% CAGR Growth, and Revenue Forecast Rising from US$ 34.2 Billion in 2025 to US$ 42.0 Billion by 2036
Specialty Surfactants Market Outlook 2036: Bio-Based Dominance, 1.9% CAGR Growth …
The global Specialty Surfactants Market reached a valuation of US$ 34.2 Billion in 2025 and is projected to climb to US$ 42.0 Billion by 2036, expanding at a steady CAGR of 1.9% from 2026 to 2036. While the growth rate reflects a mature yet stable industry, the sector continues to witness structural shifts driven by sustainability mandates, innovation in bio-based formulations, and expanding applications across end-use industries. Asia Pacific accounted for

All 5 Releases


More Releases for Mitotic

Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZ …
Understanding the growth potential of niche biotechnology markets reveals exciting opportunities for innovation and investment. One such area gaining attention is the mitotic spindle organizing protein 2B (MZT2B) antibody market, which is poised for remarkable expansion due to advances in medical research and technology. Let's explore the current landscape, key players, market segments, and factors driving this market forward. Projected Growth Trajectory of the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody
Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZ …
Understanding the growth potential of niche biotechnology markets reveals exciting opportunities for innovation and investment. One such area gaining attention is the mitotic spindle organizing protein 2B (MZT2B) antibody market, which is poised for remarkable expansion due to advances in medical research and technology. Let's explore the current landscape, key players, market segments, and factors driving this market forward. Projected Growth Trajectory of the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody
Mitotic Inhibitors Market Industry Analysis by Size, Share, Growth, Sourcing Str …
" The global mitotic inhibitors market is valued at approximately $4.5 billion in 2024, with projections indicating a robust growth trajectory, reaching around $8 billion by 2034. This translates to a compound annual growth rate (CAGR) of approximately 7% during the forecast period from 2025 to 2034. " Exactitude Consultancy., Ltd. released a research report titled "Mitotic Inhibitors Market". This report covers the global Mitotic Inhibitors market sales, sales volume, price,
Mitotic Inhibitors Market Industry Analysis by Size, Share, Growth, Sourcing Str …
" The global mitotic inhibitors market is valued at approximately $4.5 billion in 2024, with projections indicating a robust growth trajectory, reaching around $8 billion by 2034. This translates to a compound annual growth rate (CAGR) of approximately 7% during the forecast period from 2025 to 2034. " Exactitude Consultancy., Ltd. released a research report titled "Mitotic Inhibitors Market". This report covers the global Mitotic Inhibitors market sales, sales volume, price,
Mitotic Inhibitors Market Size, Company Profiles and Key Figures Reviewed in Lat …
Mitotic Inhibitors market research report involves a key data and information about the market, emerging trends, product usage, motivating factors for customers and competitors, restraints, brand positioning, and customer behaviour, which is of utmost importance when it comes to achieving a success in the competitive marketplace. Thus, the report deals with plentiful aspects of the healthcare industry. This market report provides CAGR value fluctuation during the forecast period of the
Mitotic Inhibitors Market Growth, Size, Opportunities, Trends, Regional Overview …
Stratagem Market Insights recently released a survey report on "Mitotic Inhibitors Market - Status and Forecast to 2030". A detailed study accumulated to offer the Latest insights about acute features of the Mitotic Inhibitors market. The report aims to deliver a detailed outline of the changing trends, growth scenarios, and market development activities to strategize business activities with useful strategies. In order to derive profitable and sustainable growth, Mitotic Inhibitors